December 15, 2016
NOXXON/Merck to study drugs combination in cancer treatment
NOXXON Pharma N.V. has announced a collaboration with Merck & Co. (MSD), Inc, under which the two companies will collaborate…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: NOX-A12
October 10, 2016
NOXXON: NOX-A12 synergizes with both T cell and NK cell based therapies
NOXXON Pharma N.V. a clinical-stage biopharmaceutical company primarily focused on cancer treatment, announced that it presented data yesterday at the ESMO conference in Copenhagen, Denmark, studying the role of CXCL12 inhibition by NOX-A12 (olaptesed pegol) in tumor stroma spheroids, a preclinical model that mimics the complexity of the tumor microenvironment.